The Valley Desk

ArticleJournal of gastrointestinal oncologyPublished

Treatment discontinuation associated with perioperative toxicity of FLOT versus XELOX chemotherapy in patients with resectable gastric cancer: prospective randomized trial (PECORINO)

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Journal of gastrointestinal oncology
Published
Subject terms
Gastric cancer; Perioperative Chemotherapy; 5-Fluorouracil, Leucovorin, Oxaliplatin And Docetaxel (Flot); Capecitabine And Oxaliplatine (Xelox); Protocol Completion
PubMed ID
40672074
PubMed Central ID
PMC12260966
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal